Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Promethazine for reducing restlessness during pediatric eye examinations
IRCT20200406046969N1Phase 3Completed
- Sponsor
- Zahedan University of Medical Sciences
- Start
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of promethazine in None and anxiety disorder (2 arms), sponsored by Zahedan University of Medical Sciences. Primary endpoints: Aggressive behavior during the examination, Shocking movements during the examination and 1 more. Started Feb 2020; status: completed.
02
Drugs
promethazine
03
Conditions
anxiety disorder
Beyond the preview
Go deeper on IRCT20200406046969N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200406046969N1.